News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
The role of TP53 and ctDNA kinetics in patients with R/R DLBCL
Photo of Carmelo Carlo-Stella from ematologyonair.com
Jul 16, 2024, 23:11

The role of TP53 and ctDNA kinetics in patients with R/R DLBCL

VJHemOnc (The Video Journal of Hematology and Hematological Oncology) shared a post on X:

”In an insightful recent interview, Carmelo Carlo-Stella (Humanitas University) speaks on the role of TP53 and ctDNA kinetics in patients with relapsed or refractory diffuse large B-cell lymphoma treated with glofitamab monotherapy. Watch here.”

Source: VJHemOnc/X

B-cell lymphoma cancer Carmelo Carlo-Stella glofitamab Humanitas University OncoDaily Oncology The Video Journal of Hematology and Hematological Oncology VJHemOnc
Special Coverage
Blog
Nov 19, 2024, 12:27
Lung Cancer Awareness Month Highlights by Lauren Kriger Groner
Blog
Nov 19, 2024, 12:21
OncoInfluencers to Follow on Social Media: Dr. Justin Stebbing
Blog
Nov 19, 2024, 10:22
Ilana Schlam: Updated treatment algorithms for Breast Cancer include adjuvant Ribociclib and Inavolisib
Insight
Nov 19, 2024, 10:18
Anita McGrath’s Advocacy Journey in Lung Cancer - IASLC
Blog
Nov 19, 2024, 10:10
The AACR is accepting submissions for the 2025 June L. Biedler Prize for Cancer Journalism
Blog
Nov 19, 2024, 10:05
NCCN in the 4th 2024 CCHIO
Blog
Nov 19, 2024, 09:59
Emad Shash: Another milestone in our journey of providing world-class cancer care in Upper Egypt
Blog
Nov 19, 2024, 09:53
Tackling Cancer Inequalities in North East London Cancer Alliance
Blog
Nov 19, 2024, 09:44
Association of Limited Health Literacy Among Older Adults With Cancer
Blog
Nov 19, 2024, 09:40
Runcie Chidebe: Excited to receive the 2024 James McKenny Award from AGHE
Blog
Nov 19, 2024, 09:36
Helena Yu on why lung cancer is more common in women than men in the 35-to-54 age group - MSKCC
Blog
Nov 19, 2024, 09:33
Abstract Submission for the 2025 edition of Drugging and Regulating the MAP Kinase Pathway - EACR